Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy

European Journal of Nuclear Medicine

Volumn 24, Issue 3, 1997, Pages 286-292

  Gyenes, Gábor ^a,c   Fornander, Tommy ^a   Carlens, Per ^a   Glas, Ulla ^a   Rutqvist, Lars Erik ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Breast cancer; Microvascular damage; Radiotherapy; Technetium 99m sestamibi myocardial perfusion scintigraphy

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; EARLY CANCER; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE INJURY; HEART SCINTISCANNING; HUMAN; PROGNOSIS; PROSPECTIVE STUDY; RADIATION INJURY; SCINTIGRAPHY;

BREAST NEOPLASMS; CORONARY DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, HIGH-ENERGY; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0030895749     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050054     Document Type: Article

References (17)

1. Stewart JR, Fajardo LF. Radiation-induced heart disease: and update. Prog Cardiovasc Dis 1984; 27: 173-194.
2. Corn BW, Trock BJ, Goodman RL. Irradiation-related ischemic heart disease. J Clin Oncol 1990; 8: 741-750.
3. Rutqvist LE, Johansson H. Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer 1990; 61: 866-868.
4. Cuzick J, Stewart H, Peto R, Baum M, Fisher B, Host H, Lythgoe J. Ribeiro G, Scheurlen H, Wallgren A. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 1987; 71: 15-29.
5. Cuzick J, Stewart H, Rutqvist LE, Houghton J, Edwards R, Redmond C, Peto R, Baum M, Fisher B, Host H, Lythgoe J, Ribeiro G, Scheurlen H. Cause-specific mortality in long term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12: 447-453.
6. Braunwald E. Heart disease. A textbook of cardiovascular medicine. Philadelphia: W.B. Saunders, 1992.
7. Beller GA. Myocardial perfusion imaging with thallium-201. In: Marcus ML, Scheibert HR, Skorton DJ, Wolf GL, Braunwald E, eds. Cardiac imaging. Philadelphia: W.B. Saunders; 1991: 1047-1069.
8. Gyenes G, Fornander T, Carlens P, Rutqvist LE. Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 1994; 28: 1235-1241.
9. Faragó K, Gyenes G. Pericardial irritation in breast cancer patiens treated by curative postoperative radiotherapy - early results. Strahlenther Onkol 1991; 167: 201-207.
10. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik AJ (The American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms). Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-367.
11. DePuey EG, Garcia EV, Alasraki NF, Robbins WL, Folks RD. Comparison of thallium-201 and Tc-99m MIBI for quantitative SPECT [abstract]. J Nucl Med 1988; 29: 793.
12. DePuey EG, Garcia EV. Optimal specificity of thallium-201 SPECT through recognition of imaging artifacts. J Nucl Med 1989; 30: 441-449.
13. Eisner RL, Tamas MJ, Cloninger K, Shonkoff D, Oates JA, Gober AM, Dunn DW, Malko JA, Churchwell AL, Patterson RE. Normal SPECT thallium-201 bull's-eye display: gender differences. J Nucl Med 1988; 29: 1901-1909.
14. Niemtzow RC, Reynolds RD. Radiation therapy and the heart. In: Kapoor AS, Reynolds RD, eds. Cancer and the heart. New York Berlin Heidelberg: Springer 1985: 232-245.
15. Carrió I, Estorch M, López-Pousa A. Assessing anthracycline cardiotoxicity in the 1990s. Eur J Nucl Med 1996; 23: 359-364.
16. Valdés Olmos RA, ten Bokkel Huinink WW, Dewit LGH, Hoefnagel CA, Liem IH, van Tinteren H. Iodine-123 metaiodobenzylguanidine in the assessment of late cardiac effects from cancer therapy. Eur J Nucl Med 1996; 23: 453-458.
17. Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist LE. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys 1996; 36: 899-905.